Table of Contents Author Guidelines Submit a Manuscript
Journal of Tropical Medicine
Volume 2014 (2014), Article ID 832029, 4 pages
http://dx.doi.org/10.1155/2014/832029
Research Article

Incidence of Tuberculosis and Amyloidosis among Sudanese Patients Presented with Enlarged Nodes

1Department of Pathology, Faculty of Medicine, University of Kordofan, El-Obied, Sudan
2Department of Pathology, College of Medicine, University of Hail, Hail 2440, Saudi Arabia

Received 8 January 2014; Accepted 24 February 2014; Published 30 March 2014

Academic Editor: Jean-Paul Gonzalez

Copyright © 2014 Ahmed Abdalla Agab Eldour et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Fontanilla, A. Barnes, and C. F. von Reyn, “Current diagnosis and management of peripheral tuberculous Lymphadenitis,” Clinical Infectious Diseases, vol. 53, no. 6, pp. 555–562, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. Dandapat, B. M. Mishra, S. P. Dash, and P. K. Kar, “Peripheral lymph node tuberculosis: a review of 80 cases,” British Journal of Surgery, vol. 77, no. 8, pp. 911–912, 1990. View at Publisher · View at Google Scholar · View at Scopus
  3. S. E. Weis, P. K. Moonan, J. M. Pogoda et al., “Tuberculosis in the foreign-born population of Tarrant County, Texas by immigration status,” The American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 6, pp. 953–957, 2001. View at Google Scholar · View at Scopus
  4. R. Iwnetu, J. van den Hombergh, Y. Woldeamanuel et al., “Is tuberculous lymphadenitis over-diagnosed in Ethiopia? Comparative performance of diagnostic tests for mycobacterial lymphadenitis in a high-burden country,” Scandinavian Journal of Infectious Diseases, vol. 41, no. 6-7, pp. 462–468, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Polesky, W. Grove, and G. Bhatia, “Peripheral tuberculous lymphadenitis: Epidemiology, diagnosis, treatment, and outcome,” Medicine, vol. 84, no. 6, pp. 350–362, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. H. G. Ahmed, A. S. Nassar, and I. Ginawi, “Screening for tuberculosis and its histological pattern in patients with enlarged lymph node,” Pathology Research International, vol. 2011, Article ID 417635, 4 pages, 2011. View at Publisher · View at Google Scholar
  7. G. S. Sharaf Eldin, I. Fadl-Elmula, M. S. Ali et al., “Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs,” BMC Infectious Diseases, vol. 11, article 219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. I. El-Sony, A. H. Khamis, D. A. Enarson, O. Baraka, S. A. Mustafa, and G. Bjune, “Treatment results of DOTS in 1797 sudanese tuberculosis patients with or without HIV co-infection,” International Journal of Tuberculosis and Lung Disease, vol. 6, no. 12, pp. 1058–1066, 2002. View at Google Scholar · View at Scopus
  9. A. G. Kibbi, N. G. Rubeiz, S. T. Zaynoun, and A. K. Kurban, “Primary localized cutaneous amyloidosis,” International Journal of Dermatology, vol. 31, no. 2, pp. 95–98, 1992. View at Google Scholar · View at Scopus
  10. S. M. Breathnach, “Amyloid and amyloidosis,” Journal of the American Academy of Dermatology, vol. 18, no. 1, pp. 1–16, 1988. View at Google Scholar · View at Scopus
  11. J. D. Sipe, M. D. Benson, J. N. Buxbaum et al., “Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis,” Amyloid, vol. 17, no. 3-4, pp. 101–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Merlini, D. C. Seldin, and M. A. Gertz, “Amyloidosis: pathogenesis and new therapeutic options,” Journal of Clinical Oncology, vol. 29, no. 14, pp. 1924–1933, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Bellotti, M. Nuvolone, S. Giorgetti et al., “The workings of the amyloid diseases,” Annals of Medicine, vol. 39, no. 3, pp. 200–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Bennhold, “Eine spezifische Amyloidfarbung mit Kongorot,” Munchener Medizinische Wochenschrift, vol. 69, pp. 1537–1538, 1922. View at Google Scholar
  15. A. S. Cohen and E. Calkins, “Electron Microscopic Observations on a fibrous component in amyloid of diverse origins,” Nature, vol. 183, no. 4669, pp. 1202–1203, 1959. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Shirahama and A. S. Cohen, “High-resolution electron microscopic analysis of the amyloid fibril,” Journal of Cell Biology, vol. 33, no. 3, pp. 679–708, 1967. View at Google Scholar · View at Scopus
  17. L. Bonar, A. S. Cohen, and M. M. Skinner, “Characterization of the amyloid fibril as a cross-beta protein,” Proceedings of the Society for Experimental Biology and Medicine, vol. 131, no. 4, pp. 1373–1375, 1969. View at Google Scholar · View at Scopus
  18. World Health Organization, “Global tuberculosis control,” WHO Report, World Health Organization, Geneva, Switzerland, 2011. View at Google Scholar
  19. M. Özvaran, R. Baran, M. Tor et al., “Extrapulmonary tuberculosis in non-human immunodeficiency virus-infected adults in an endemic region,” Annals of Thoracic Medicine, vol. 2, no. 3, pp. 118–121, 2007. View at Google Scholar · View at Scopus
  20. World Health Organisation, “Global tuberculosis control,” WHO Report, World Health Organization, Geneva, Switzerland, 2010. View at Google Scholar
  21. G. S. Sharafeldin, E. A. G. Khalil, I. A. El Hag et al., “Haematogenous dissemination of tuberculous lymphadenitis,” East African Medical Journal, vol. 84, no. 1, pp. 3–7, 2007. View at Google Scholar · View at Scopus
  22. A. K. Ageep, “Diagnosis of tuberculous lymphadenitis in Red Sea state, Sudan,” International Journal of Tropical Medicine, vol. 7, no. 1, pp. 53–56, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Hemminki, X. Li, A. Försti, J. Sundquist, and K. Sundquist, “Incidence and survival in non-hereditary amyloidosis in Sweden,” BMC Public Health, vol. 12, article 974, 2012. View at Google Scholar
  24. R. A. Kyle, A. Linos, C. M. Beard et al., “Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989,” Blood, vol. 79, no. 7, pp. 1817–1822, 1992. View at Google Scholar · View at Scopus
  25. F. K. Lekpa, S. Ndongo, A. Pouye et al., “Amyloidosis in sub-Saharan Africa,” Médecine et Santé Tropicales, vol. 22, no. 3, pp. 275–278, 2012. View at Google Scholar
  26. G. E. Silva, R. S. Costa, and M. Dantas, “Secondary amyloidosis associated with tuberculosis in renal biopsy,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 44, no. 6, p. 797, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. Le Roux, M. K. P. David, N. Peter, G. Priya, N. J. James, and E. S. Brian, “Systemic amyloidosis complicating multidrug-resistant tuberculosis in childhood,” Pediatric Infectious Disease Journal, vol. 31, no. 9, pp. 994–997, 2012. View at Publisher · View at Google Scholar
  28. E. T. Stoopler, F. Alawi, J. M. Laudenbach, and T. P. Sollecito, “Bullous amyloidosis of the oral cavity: a rare clinical presentation and review,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 101, no. 6, pp. 734–740, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Agheli, M. Becker, G. Becker, M. R. Chaudhry, and J. C. Wang, “Response of hemorrhagic bullous skin lesions of the breast secondary to primary systemic amyloidosis to a five-drug combination chemotherapy: a case report and review of the literature,” Experimental Hematology & Oncology, vol. 1, article 19, 2012. View at Google Scholar
  30. H. J. Lachmann, H. J. Goodman, J. A. Gilbertson et al., “Natural history and outcome in systemic AA amyloidosis,” The New England Journal of Medicine, vol. 356, no. 23, pp. 2361–2371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Obici, S. Raimondi, F. Lavatelli, V. Bellotti, and G. Merlini, “Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview,” Arthritis Care and Research, vol. 61, no. 10, pp. 1435–1440, 2009. View at Publisher · View at Google Scholar · View at Scopus